Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer: A Meta-analysis

Gemcitabine (GEM) is an approved treatment for unresectable pancreatic cancer; however, its role in treating resected pancreatic cancer is less clear. The aim of this study was to investigate the evidence of the role of adjuvant GEM therapy on survival in resected pancreatic cancer. Four phase III r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of clinical oncology 2015-06, Vol.38 (3), p.322-325
Hauptverfasser:	Yu, Zhong, Zhong, Wa, Tan, Zhi-Ming, Wang, Ling-Yun, Yuan, Yu-Hong
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimetabolites, Antineoplastic - therapeutic use Chemotherapy, Adjuvant Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Humans Pancreatectomy Pancreatic Neoplasms - therapy Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!